Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.



411 University St, Seattle, USA

+1 -800-456-478-23

// In Vivo Programming

Powering Immunity Through In Vivo Myeloid Programming

Myeloid’s novel in vivo engineering platform specifically targets and activates myeloid cells to elicit broader anti-tumor adaptive immunity. Through this approach, Myeloid demonstrates that delivery of lipid-nanoparticles (LNPs) encapsulating mRNA results in uptake and selective expression by myeloid cells in vivo, leading to potent tumor killing in multiple cold tumor models. These data demonstrate the potential for Myeloid’s technology to program cells directly in vivo.

Myeloid Lab
// Overcoming Limitations

Key Platform Characteristics

Leveraging RNA & LNP Technology

Cell Selectivity & Anti-Tumor Activity from Novel Fcα CAR

Versatile Platform